These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
581 related items for PubMed ID: 11934224
1. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Lestin M, Hergert M, Lestin HG, Brinker C, Storm H, Kuhrt E, Kuhrt B, Lambrecht HG, Kühnel W. Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224 [Abstract] [Full Text] [Related]
2. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader. Peetz D, Schweigert R, Jachmann N, Post F, Schinzel H, Lackner KJ. Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892 [Abstract] [Full Text] [Related]
3. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Eggers KM, Oldgren J, Nordenskjöld A, Lindahl B. Am Heart J; 2004 Oct; 148(4):574-81. PubMed ID: 15459585 [Abstract] [Full Text] [Related]
4. Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain. Chang CC, Ip MP, Hsu RM, Vrobel T. Arch Pathol Lab Med; 1998 Apr; 122(4):320-4. PubMed ID: 9648898 [Abstract] [Full Text] [Related]
5. Clinical performance of the new cardiac markers troponin T and CK-MB on the Elecsys 2010. A multicentre evaluation. Klein G, Kampmann M, Baum H, Rauscher T, Vukovic T, Hallermayer K, Rehner H, Müller-Bardorff M, Katus HA. Wien Klin Wochenschr; 1998 Apr; 110 Suppl 3():40-51. PubMed ID: 9677671 [Abstract] [Full Text] [Related]
6. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction. Kost GJ, Kirk JD, Omand K. Arch Pathol Lab Med; 1998 Mar; 122(3):245-51. PubMed ID: 9823862 [Abstract] [Full Text] [Related]
7. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S. Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277 [Abstract] [Full Text] [Related]
8. Comparison of the diagnostic utility of CK, CK-MB (activity and mass), troponin T and troponin I in patients with suspected acute myocardial infarction. Hawkins RC, Tan HL. Singapore Med J; 1999 Nov; 40(11):680-4. PubMed ID: 10709404 [Abstract] [Full Text] [Related]
9. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. Wu AH, Feng YJ, Contois JH, Pervaiz S. Ann Clin Lab Sci; 1996 Nov; 26(4):291-300. PubMed ID: 8800429 [Abstract] [Full Text] [Related]
10. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Clin Chim Acta; 2004 Aug 16; 346(2):211-9. PubMed ID: 15256323 [Abstract] [Full Text] [Related]
12. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Am Heart J; 2001 Jun 16; 141(6):985-91. PubMed ID: 11376314 [Abstract] [Full Text] [Related]
13. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience. Penttilä IM, Laatikainen A, Penttilä K, Punnonen K, Rantanen T, Savolainen K, Tiikkainen U. Scand J Clin Lab Invest; 2007 Jun 16; 67(5):507-18. PubMed ID: 17763187 [Abstract] [Full Text] [Related]
14. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass. Weber M, Rau M, Madlener K, Elsaesser A, Bankovic D, Mitrovic V, Hamm C. Clin Biochem; 2005 Nov 16; 38(11):1027-30. PubMed ID: 16125162 [Abstract] [Full Text] [Related]
15. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists. Mark B, Schneider S, Schiele R, Taubert G, Kilkowski C, Seidl K, Nagel D, Seiler D, Senges J, Zahn R. Z Kardiol; 2003 Dec 16; 92(12):1018-24. PubMed ID: 14663612 [Abstract] [Full Text] [Related]
16. [Serum markers for ischemic myocardial damage]. Fontes JP, Gonçalves M, Ribeiro VG. Rev Port Cardiol; 1999 Dec 16; 18(12):1129-36. PubMed ID: 10661020 [Abstract] [Full Text] [Related]
17. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS. Am Heart J; 2001 Jul 16; 142(1):29-36. PubMed ID: 11431653 [Abstract] [Full Text] [Related]
18. Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system. Bohuslavizki KH, vom Baur E, Weger B, Krebs C, Saller B, Wetlitzky O, Musiol N, Kühnel W, Lambrecht HG, Clausen M. Clin Lab; 2000 Jul 16; 46(1-2):23-31. PubMed ID: 10745978 [Abstract] [Full Text] [Related]
19. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction]. Xiao HG, Huang ZH, Liu HX, Lin YP. Di Yi Jun Yi Da Xue Xue Bao; 2005 May 16; 25(5):550-1. PubMed ID: 15897132 [Abstract] [Full Text] [Related]
20. Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome. Saadeddin SM, Habbab MA, Siddieg HH, Al Seeni MN, Tahery AB, Dafterdar RM. Saudi Med J; 2003 Oct 16; 24(10):1092-7. PubMed ID: 14578975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]